Kimia Farma Persero Tbk Cash Flow Conversion Efficiency
Kimia Farma Persero Tbk cash flow conversion efficiency. Based on the latest financial reports, Kimia Farma Persero Tbk (KAEF) has a cash flow conversion efficiency ratio of -0.065x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp-180.20 Billion ≈ $-10.56 Million USD) by net assets (Rp2.79 Trillion ≈ $163.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Kimia Farma Persero Tbk (2003–2025)
Cash flow conversion efficiency of Kimia Farma Persero Tbk from 2003 to 2025. This chart illustrates how Kimia Farma Persero Tbk's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Kimia Farma Persero Tbk stock quote for real-time trading data and today's change.
Kimia Farma Persero Tbk Cash Flow Conversion Ratio Explained
Kimia Farma Persero Tbk cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Kimia Farma Persero Tbk Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kimia Farma Persero Tbk ranked by their cash flow conversion efficiency. Also see KAEF market cap overview for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Asuransi Multi Artha Guna Tbk PT
JK:AMAG
|
0.010x |
|
Jw Life Science Corp
KO:234080
|
0.077x |
|
Min Aik Technology Co Ltd
TW:3060
|
-0.028x |
|
Anavex Life Sciences Corp
NASDAQ:AVXL
|
-0.120x |
|
TCM Group
CO:TCM
|
0.087x |
|
LifeMD Inc
NASDAQ:LFMD
|
-0.142x |
|
Honghua Group Limited
F:4HB
|
0.011x |
|
Sidus Space Inc
NASDAQ:SIDU
|
-0.018x |
Annual Cash Flow Conversion Efficiency for Kimia Farma Persero Tbk (2003–2025)
The table below shows the annual cash flow conversion efficiency of Kimia Farma Persero Tbk from 2003 to 2025. Review Kimia Farma Persero Tbk free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Rp2.51 Trillion ≈ $147.06 Million |
Rp236.75 Billion ≈ $13.87 Million |
0.094x | +110.55% |
| 2024-12-31 | Rp3.43 Trillion ≈ $200.91 Million |
Rp153.62 Billion ≈ $9.00 Million |
0.045x | +178.56% |
| 2023-12-31 | Rp6.39 Trillion ≈ $374.59 Million |
Rp-364.58 Billion ≈ $-21.36 Million |
-0.057x | -232.05% |
| 2022-12-31 | Rp9.34 Trillion ≈ $547.25 Million |
Rp403.34 Billion ≈ $23.63 Million |
0.043x | +239.48% |
| 2021-12-31 | Rp7.23 Trillion ≈ $423.76 Million |
Rp-223.92 Billion ≈ $-13.12 Million |
-0.031x | -121.59% |
| 2020-12-31 | Rp7.11 Trillion ≈ $416.36 Million |
Rp1.02 Trillion ≈ $59.71 Million |
0.143x | +157.34% |
| 2019-12-31 | Rp7.41 Trillion ≈ $434.37 Million |
Rp-1.85 Trillion ≈ $-108.63 Million |
-0.250x | -528.82% |
| 2018-12-31 | Rp3.36 Trillion ≈ $196.68 Million |
Rp195.75 Billion ≈ $11.47 Million |
0.058x | +359.68% |
| 2017-12-31 | Rp2.57 Trillion ≈ $150.74 Million |
Rp32.64 Billion ≈ $1.91 Million |
0.013x | -86.50% |
| 2016-12-31 | Rp2.27 Trillion ≈ $133.10 Million |
Rp213.43 Billion ≈ $12.51 Million |
0.094x | -13.74% |
| 2015-12-31 | Rp1.86 Trillion ≈ $109.11 Million |
Rp202.84 Billion ≈ $11.89 Million |
0.109x | -31.09% |
| 2014-12-31 | Rp1.81 Trillion ≈ $106.13 Million |
Rp286.31 Billion ≈ $16.78 Million |
0.158x | +1.18% |
| 2013-12-31 | Rp1.62 Trillion ≈ $95.18 Million |
Rp253.78 Billion ≈ $14.87 Million |
0.156x | -2.34% |
| 2012-12-31 | Rp1.44 Trillion ≈ $84.47 Million |
Rp230.61 Billion ≈ $13.51 Million |
0.160x | +138.80% |
| 2011-12-31 | Rp1.25 Trillion ≈ $73.39 Million |
Rp83.91 Billion ≈ $4.92 Million |
0.067x | -47.21% |
| 2010-12-31 | Rp1.11 Trillion ≈ $65.28 Million |
Rp141.37 Billion ≈ $8.28 Million |
0.127x | +3.52% |
| 2009-12-31 | Rp995.32 Billion ≈ $58.32 Million |
Rp122.01 Billion ≈ $7.15 Million |
0.123x | +504.90% |
| 2008-12-31 | Rp947.76 Billion ≈ $55.54 Million |
Rp-28.69 Billion ≈ $-1.68 Million |
-0.030x | -149.52% |
| 2007-12-31 | Rp908.03 Billion ≈ $53.21 Million |
Rp55.51 Billion ≈ $3.25 Million |
0.061x | -62.05% |
| 2006-12-31 | Rp870.65 Billion ≈ $51.02 Million |
Rp140.24 Billion ≈ $8.22 Million |
0.161x | +344.45% |
| 2005-12-31 | Rp844.22 Billion ≈ $49.47 Million |
Rp30.60 Billion ≈ $1.79 Million |
0.036x | -91.31% |
| 2003-12-31 | Rp754.46 Billion ≈ $44.21 Million |
Rp314.63 Billion ≈ $18.44 Million |
0.417x | -- |
About Kimia Farma Persero Tbk
PT Kimia Farma Tbk, together with its subsidiaries, manufactures and sells a range of medicines in Indonesia and internationally. It operates through Manufacture, Distribution, Retail, and Others segments. The company offers drugs in the form of tablets, effervescent tablets, hard and soft capsules, liquids, syrups, oral powders, non-beta-lactam external liquids, beta-lactam tablets and dry syrup… Read more